
Gyounghyun Bae
Examiner (ID: 13117, Phone: (571)270-5942 , Office: P/3742 )
| Most Active Art Unit | 3742 |
| Art Unit(s) | 3761, 3742, 3724 |
| Total Applications | 566 |
| Issued Applications | 395 |
| Pending Applications | 1 |
| Abandoned Applications | 171 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17958617
[patent_doc_number] => 20220339197
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => USE OF HEMATOPOIETIC STEM CELLS IN PREPARATION OF FORMULATION FOR TREATING VIRAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/766071
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17766071
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/766071 | USE OF HEMATOPOIETIC STEM CELLS IN PREPARATION OF FORMULATION FOR TREATING VIRAL DISEASES | Oct 13, 2020 | Abandoned |
Array
(
[id] => 18595997
[patent_doc_number] => 20230270788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => COMPOSITION FOR AUGMENTING STEMNESS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/767453
[patent_app_country] => US
[patent_app_date] => 2020-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17767453
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/767453 | COMPOSITION FOR AUGMENTING STEMNESS AND USE THEREOF | Oct 7, 2020 | Abandoned |
Array
(
[id] => 17807827
[patent_doc_number] => 20220259662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => BIOMARKER COMPOSITION FOR PREDICTING THERAPEUTIC EFFECT OF MESENCHYMAL STEM CELLS ON RENAL FIBROSIS
[patent_app_type] => utility
[patent_app_number] => 17/765695
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5996
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765695
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/765695 | BIOMARKER COMPOSITION FOR PREDICTING THERAPEUTIC EFFECT OF MESENCHYMAL STEM CELLS ON RENAL FIBROSIS | Sep 28, 2020 | Pending |
Array
(
[id] => 17961334
[patent_doc_number] => 20220341915
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => LUNG FIBROSIS MODEL AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/763991
[patent_app_country] => US
[patent_app_date] => 2020-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16565
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763991
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763991 | LUNG FIBROSIS MODEL AND METHODS OF USING THE SAME | Sep 27, 2020 | Pending |
Array
(
[id] => 17958621
[patent_doc_number] => 20220339201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-27
[patent_title] => FIBROBLAST AND FIBROBLAST-IMMUNOCYTE COMBINATIONS FOR TREATMENT OF SUBCONCUSSIVE- AND CONCUSSIVE-ASSOCIATED NEUROLOGICAL DAMAGE
[patent_app_type] => utility
[patent_app_number] => 17/753491
[patent_app_country] => US
[patent_app_date] => 2020-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -60
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753491
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/753491 | FIBROBLAST AND FIBROBLAST-IMMUNOCYTE COMBINATIONS FOR TREATMENT OF SUBCONCUSSIVE- AND CONCUSSIVE-ASSOCIATED NEUROLOGICAL DAMAGE | Sep 8, 2020 | Pending |
Array
(
[id] => 18005308
[patent_doc_number] => 20220364074
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/634723
[patent_app_country] => US
[patent_app_date] => 2020-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17634723
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/634723 | RNA-GUIDED NUCLEASES AND ACTIVE FRAGMENTS AND VARIANTS THEREOF AND METHODS OF USE | Aug 10, 2020 | Pending |
Array
(
[id] => 17807729
[patent_doc_number] => 20220259564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => METHOD OF CULTURING MESENCHYMAL STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/627500
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12353
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17627500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/627500 | METHOD OF CULTURING MESENCHYMAL STEM CELLS | Jul 14, 2020 | Abandoned |
Array
(
[id] => 20384869
[patent_doc_number] => 12484575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Mosquito egg cryopreservation
[patent_app_type] => utility
[patent_app_number] => 17/626381
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 8316
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626381
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626381 | Mosquito egg cryopreservation | Jul 12, 2020 | Issued |
Array
(
[id] => 17988864
[patent_doc_number] => 20220354901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => METHODS OF FUNCTIONAL VASCULARIZATION OF PANCREATIC ISLETS AND BETA-CELL ORGANOIDS
[patent_app_type] => utility
[patent_app_number] => 17/623493
[patent_app_country] => US
[patent_app_date] => 2020-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32707
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17623493
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/623493 | METHODS OF FUNCTIONAL VASCULARIZATION OF PANCREATIC ISLETS AND BETA-CELL ORGANOIDS | Jul 1, 2020 | Pending |
Array
(
[id] => 18297555
[patent_doc_number] => 20230107241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => ANTI-INFLAMMAATORY AND ANTI-VIRAL COMPOSITION BASED ON PLACENTA-DERIVED EXTRACELLULAR VESICLE
[patent_app_type] => utility
[patent_app_number] => 17/603459
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17603459
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/603459 | ANTI-INFLAMMAATORY AND ANTI-VIRAL COMPOSITION BASED ON PLACENTA-DERIVED EXTRACELLULAR VESICLE | Jun 24, 2020 | Pending |
Array
(
[id] => 17759984
[patent_doc_number] => 20220233596
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => Modified NK-92 cells, and therapeutic and diagnostic uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/614900
[patent_app_country] => US
[patent_app_date] => 2020-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7956
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17614900
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/614900 | Modified NK-92 cells, and therapeutic and diagnostic uses thereof | Jun 8, 2020 | Pending |
Array
(
[id] => 17928381
[patent_doc_number] => 20220323506
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => Oligodendrocyte-derived Extracellular Vesicles for Therapy of Multiple Sclerosis
[patent_app_type] => utility
[patent_app_number] => 17/615975
[patent_app_country] => US
[patent_app_date] => 2020-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15530
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615975
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615975 | Oligodendrocyte-derived extracellular vesicles for therapy of multiple sclerosis | Jun 2, 2020 | Issued |
Array
(
[id] => 20402410
[patent_doc_number] => 12492380
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-09
[patent_title] => Methods for the production of hepatocytes
[patent_app_type] => utility
[patent_app_number] => 17/610123
[patent_app_country] => US
[patent_app_date] => 2020-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 54
[patent_figures_cnt] => 46
[patent_no_of_words] => 14209
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17610123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/610123 | Methods for the production of hepatocytes | May 10, 2020 | Issued |
Array
(
[id] => 19113139
[patent_doc_number] => 20240124889
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => COMPOSITIONS AND METHODS FOR THE VECTORED AUGMENTATION OF PROTEIN DESTRUCTION, EXPRESSION AND/OR REGULATION
[patent_app_type] => utility
[patent_app_number] => 17/609170
[patent_app_country] => US
[patent_app_date] => 2020-05-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 355057
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609170
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609170 | COMPOSITIONS AND METHODS FOR THE VECTORED AUGMENTATION OF PROTEIN DESTRUCTION, EXPRESSION AND/OR REGULATION | May 6, 2020 | Abandoned |
Array
(
[id] => 20025181
[patent_doc_number] => 20250163403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-05-22
[patent_title] => METHOD OF INTRODUCING A PLURALITY OF GENE DRIVES INTO A POPULATION
[patent_app_type] => utility
[patent_app_number] => 17/607138
[patent_app_country] => US
[patent_app_date] => 2020-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17607138
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/607138 | METHOD OF INTRODUCING A PLURALITY OF GENE DRIVES INTO A POPULATION | Apr 30, 2020 | Abandoned |
Array
(
[id] => 18309202
[patent_doc_number] => 20230113102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => ENGINEERED CRY PROTEINS FOR DELIVERY OF THERAPEUTICS
[patent_app_type] => utility
[patent_app_number] => 17/602980
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17602980
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/602980 | Engineered cry proteins for delivery of therapeutics | Apr 14, 2020 | Issued |
Array
(
[id] => 17734968
[patent_doc_number] => 20220220427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => CULTURE CONTAINER FOR CULTURING EPITHELIAL CELLS AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/612153
[patent_app_country] => US
[patent_app_date] => 2020-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12680
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17612153
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/612153 | CULTURE CONTAINER FOR CULTURING EPITHELIAL CELLS AND USE THEREOF | Mar 22, 2020 | Issued |
Array
(
[id] => 17444166
[patent_doc_number] => 20220064671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => METHODS AND SYSTEMS FOR PRODUCING AAV PARTICLES
[patent_app_type] => utility
[patent_app_number] => 17/423737
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 139778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 331
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423737
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423737 | METHODS AND SYSTEMS FOR PRODUCING AAV PARTICLES | Jan 16, 2020 | Abandoned |
Array
(
[id] => 19909357
[patent_doc_number] => 12285546
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-04-29
[patent_title] => Animal fat-derived extracellular matrix, and preservation solution of animal fat-derived extracellular matrix
[patent_app_type] => utility
[patent_app_number] => 17/594602
[patent_app_country] => US
[patent_app_date] => 2019-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 13
[patent_no_of_words] => 1988
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17594602
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/594602 | Animal fat-derived extracellular matrix, and preservation solution of animal fat-derived extracellular matrix | Nov 20, 2019 | Issued |
Array
(
[id] => 17214791
[patent_doc_number] => 20210348128
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-11
[patent_title] => MAKING AND USING CARDIOPOIETIC CELLS
[patent_app_type] => utility
[patent_app_number] => 17/278380
[patent_app_country] => US
[patent_app_date] => 2019-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17278380
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/278380 | Making and using cardiopoietic cells | Sep 26, 2019 | Issued |